Allelic variants of the canine heavy neurofilament (NFH) subunit and extensive phosphorylation in dogs with motor neuron disease
- PMID: 15629478
- DOI: 10.1016/j.jcpa.2004.06.003
Allelic variants of the canine heavy neurofilament (NFH) subunit and extensive phosphorylation in dogs with motor neuron disease
Abstract
Aberrant accumulation of extensively phosphorylated heavy (high molecular weight) neurofilament (NFH) and neurodegeneration are features of hereditary canine spinal muscular atrophy (HCSMA), an animal model of human motor neuron disease. In this study, the canine NFH gene was mapped, cloned, and sequenced, and electrospray/mass spectrometry was used to evaluate the phosphorylation state of NFH protein from normal dogs and dogs with HCSMA. The canine NFH gene was localized to a region on canine chromosome 26 that corresponds to human NFH on chromosome 22q. The predicted length of the canine NFH protein is 1135 amino acids, and it shares an 80.3% identity with human NFH and >74.6% with murine NFH proteins. Direct sequencing of NFH cDNA from HCSMA dogs revealed no mutations, although cDNA sequence and restriction fragment length polymorphism (RFLP) analysis indicates that there are at least three canine NFH alleles, differing in the position and number (61 or 62) of Lys-Ser-Proline (KSP) motifs. The two longest alleles (L1 and L2), each with 62 KSP repeats, contain an additional 24-base insert and were observed in both normal and HCSMA dogs. However, the shorter allele (the C allele), with 61 KSP sites and lacking the 24-base insertion, was absent in dogs with HCSMA. Mass spectrometry data indicated that almost all of the NFH KSP phosphorylation sites were occupied. No new or extra sites were identified in native NFH purified from the HCSMA dogs. The predominance of the two longest NFH alleles and the additional KSP phosphorylation sites they confer probably account for the presence of extensively phosphorylated NFs detected immunohistochemically in dogs with HCSMA.
Similar articles
-
Alterations in neurofilament mRNA in hereditary canine spinal muscular atrophy.Lab Invest. 1993 Oct;69(4):436-42. Lab Invest. 1993. PMID: 8231111
-
Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry.Biochemistry. 2004 Feb 24;43(7):2091-105. doi: 10.1021/bi030196q. Biochemistry. 2004. PMID: 14967049
-
Changes in neuronal size and neurotransmitter marker in hereditary canine spinal muscular atrophy.Lab Invest. 1989 Jul;61(1):69-76. Lab Invest. 1989. PMID: 2568515
-
Hereditary canine spinal muscular atrophy: an animal model of motor neuron disease.Can J Neurol Sci. 1991 Aug;18(3 Suppl):432-4. doi: 10.1017/s0317167100032613. Can J Neurol Sci. 1991. PMID: 1933694 Review.
-
Spinal muscular atrophy, John Griffin, and mentorship.J Peripher Nerv Syst. 2012 Dec;17 Suppl 3:52-6. doi: 10.1111/j.1529-8027.2012.00432.x. J Peripher Nerv Syst. 2012. PMID: 23279433 Review.
Cited by
-
Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.Exp Cell Res. 2007 Jun 10;313(10):2098-109. doi: 10.1016/j.yexcr.2007.04.010. Epub 2007 Apr 12. Exp Cell Res. 2007. PMID: 17498690 Free PMC article. Review.
-
Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins.J Neurosci. 2009 Nov 25;29(47):14869-80. doi: 10.1523/JNEUROSCI.4469-09.2009. J Neurosci. 2009. PMID: 19940183 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical